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Abstract
We present a unique case of hepatocellular carcinoma with mucin-producing gland formation.
A 53-year-old man with hepatitis B infection presented with weight loss for the past month.
Computed tomography demonstrated a 10 × 9.8 cm mass in the right hepatic lobe accompanied by
cirrhotic changes in the hepatic parenchyma. Right hepatectomy was performed, and the tumor cut
surface showed a poorly-circumscribed, white to pink tumor with numerous nodules and extensive
necrosis. Microscopically, the tumor was composed of thick trabeculae and large, irregularly-shaped
islands, both of which were filled with pleomorphic eosinophilic hepatoid cells or gland-forming
columnar cells with mucin production. Those cells were immunoreactive for cytokeratin 19 in both
the trabeculae and the glands. In some tumor cells, limited immunoreactivity for cytokeratin 7,
epithelial membrane antigen and carcinoembryonic antigen was noted. The cells forming thick
trabeculae were focally positive for hepatocyte paraffin 1 and alpha-fetoprotein. We suggest that this
tumor shows bidirectional differentiation into hepatocytes and cholangiocytes, supporting the
concepts that human hepatocarcinogenesis can be based on transformation of progenitor cells which
can imply divergent differentiation.
Introduction
The majority of the primary liver cancers can be classified
histologically as either hepatocellular carcinoma (HCC) or
cholangiocarcinoma (CC). Combined hepatocellular and
cholangiocarcinomas (CHCs) account for only a small
portion, with varying incidence up to 6.3% [1,2]. CHC is
defined as a tumor containing unequivocal elements of
both hepatocellular and cholangiocarcinoma [3]. The
diagnostic criteria of CHCs remain still unclear, reflecting
the heterogeneity of the histologic features of CHCs. Their
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nogenesis. We present a unique case of primary liver
carcinoma with dual phenotype of hepatocytes and
cholangiocytes.
Case presentation
A 53-year-old Korean male presented with a liver tumor
detected at another hospital during check-up for weight
loss for the past month. His past medical history revealed
that he had been a hepatitis B(HB) virus carrier. His family
history was noncontributory. Serologic examination on
admission was positive for HB surface antigen, and
negative for HB surface antibody, hepatitis C virus,
hepatitis A virus, and human immunodeficiency virus.
The indocyanine green retention rate at 15 min (ICGR15)
was 26.5%. Other laboratory tests revealed elevated levels
of serum alkaline phosphatase (137 IU/L), carcinoem-
bryonic antigen (CEA, 9.42 ng/ml), alpha-fetoprotein
(AFP, 93.2 IU/ml), carbohydrate antigen 19-9 (CA19-9,
500.8 U/ml), and aspartate transaminase (AST, 54 IU/L).
Blood analysis, serum electrolytes, and other hepatic
function tests were within the normal ranges. His blood
glucose level on admission was as high as 652 mg/dl, but
had been well controlled by oral hypoglycemic agents
during his hospital stay. Computed tomography (CT) scan
showed a 10 × 9.8 cm heterogeneously enhancing mass in
the right hepatic lobe (Figure 1). The lesion was
accompanied by cirrhotic changes in the hepatic parench-
yma andtumoral thrombosis in the right portal vein. Right
hepatectomy with cholecystectomy was performed. The
tumor was described by the surgeon to involve the whole
right hepatic lobe. Two weeks postoperatively, CT scan
displayed substantial regrowth of the residual masses
(3.2 cm and 1 cm, respectively). The patient underwent
transcatheter arterial chemoembolization. However, he
developed uncontrolled gastric ulcer bleeding and hepatic
encephalopathy. He died three months after the surgery.
Pathological findings After right hepatectomy, a 16 × 11 ×
11 cm liver specimen weighing 875 g was submitted. The
tumor cut surface showed a poorly-circumscribed, firm,
white to pink tumor with numerous nodules (Figure 2).
Microscopic examination revealed a predominantly HCC
with a widespread permeation to the surrounding cirrhotic
parenchyma. Typical HCC lesions showed both solid and
trabecular patterns with extensive geographical necrosis.
Some of the tumor cells revealed hepatoid features, i.e.
abundant eosinophilic cytoplasm and moderate nuclear
atypism (Figure 3A). In a larger portion, tumor cells
showed a unique growth pattern in which thick trabeculae
or irregularly shaped tumor islands were filled with
compact or loose mucin-producing glands (Figure 3B).
Glandular portions consisted of relatively regular colum-
nar cells without intervening desmoplastic stroma. The
columnar cells had hyperchromatic nuclei in the ablum-
inal side and moderate amount of eosinophilic cytoplasm
with the formation of apical microvilli (Figure 3C). Some
of those cells contained abundant intracytoplasmic mucin,
creating signet-ring cell features. The gland-filled areas
were occupying more than 70% of tumor components,
which was confirmed with periodic acid-Schiff staining
after diastase treatment. Bile production was not seen. In
Figure 1. Computed tomography scan of the abdomen
shows a large liver mass with heterogeneous enhancement
in the right hepatic lobe.
Figure 2. The tumor cut surface displays a poorly
circumscribed, white to pink mass with extensive necrosis.
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organized in clusters, sometimes forming flattened tubular
structures. Proliferative biliary epithelia with tubule-
formation or mucin-production were easily found
between cirrhotic nodules near larger bile ducts.
For immunohistochemical studies, paraffin-embedded
tissue was stained using the avidin-biotin peroxidase
complex method. Tissue sections were incubated with
primary antibodies against cytokeratin (CK)7, CK19,
CK20, AE1, AE3, CEA, epithelial membrane antigen
(EMA), AFP, hepatocyte paraffin 1 (HepPar1), c-kit,
CD34, synaprophysin. The antibodies used are summar-
ized in the table (Table 1). Tumor cell cytoplasm in both
the trabecular and the glandular areas showed diffuse
strong immunoreactivity for CK19 (Figure 3D). In some
glandular portions, limited positivity for CK7, EMA and
CEA was noted. Small tubule-forming cells at the margins
of cirrhotic nodules were highlighted by CK7 and CK19
staining but onlya few cells werepositive for HepPar1. The
cells forming thick trabeculae were focally positive for
HepPar1 and AFP. Those antibodies known as hepatic
progenitor markers, i.e., c-kit, CD34, chromogranin-A
could not detect positively stained cells. These immuno-
histologic features confirmed the dual phenotypic differ-
entiation of the present tumor into both hepatocytes and
biliary epithelium.
Conclusions
CHC is a rare primary liver carcinoma containing both
elements of hepatocellular and cholangiocarcinoma [3].
Clinically, CHC has overlapping features with HCC;
hepatic cirrhosis and common viral markers are often
positive, and the AFP level is frequently elevated. Taguchi
et al. described clinical features of CHCs different from
those of ordinary HCC [1]. Serum levels of AFP were
relatively low in most cases. The positive rate and serum
level of CEA was also low. Although CHC is more closely
related to HCC than to CC, it follows a more aggressive
clinical course than that of ordinary HCC. Each researcher,
however, reported various incidences of hepatitis and
cirrhosis due to differing etiology depending on reporting
areas [1,2].
Figure 3. (A) Hepatoid tumor cells showing eosinophilic
cytoplasm and moderate nuclear atypism (Original
magnification×200,H&Estain).(B)Looselyarrangedglandular
structures intermingled with geographic necrosis (Original
magnification × 100, H&E stain). (C) Columnar cells forming
regular glands without desmoplasia (Original magnification
×200,H&Estain).(D)Immunoreactivityofboththetrabecular
portion and the glandular portion for CK19 (Original
magnification × 200, avidin-biotin-peroxidase stain).
Table 1. Antibodies used and immunohistochemical results
Specificity Clones Dilution Pretreatment Manufacturer Results
Tumor Cirrhotic nodule
Trabeculae Glands Tubule Hepatic
cord
CK7 OV-TL 12/
30
1:200 pepsin Dako, Glostrup,
Denmark
+* + ++ +
CK19 RCK108 1:200 pepsin Dako ++ ++ + -
CK20 Ks20.8 1:200 pepsin Dako ++ ++ - -
AE1 AE1 2¥
(predilute)
pepsin Zymed,
San-Francisco, CA
++ ++ + -
AE3 AE3 1:200 pepsin Zymed - - - -
CEA polyclonal 1:200 pepsin Zymed + + - -
EMA E29 1:400 pepsin Dako +/- + + -
AFP ZSA06 1:200 pepsin Zymed + - - -
HepPar1 OCH1E5 1:150 microwave Dako + - +/- -
c-kit 1:150 microwave Dako - - - -
CD34 QBEnd 10 1:400 pepsin Dako - - - -
Chromogranin-A DAK-A3 1:200 microwave Dako - - - -
* Staining intensity: ++, strong; +, weak; -, absence.
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diagnostic features still remain controversial. Of those
classifications, a widely accepted classification by Taguchi
et al. is as follows: 1) type I, in which each area consisting
of HCC or CC is clearly separable; 2) type II, in which the
HCC and CC areas are contiguous with an intervening area
of transition; and 3) type III, in which the tumor was not
readily classifiable as HCC and CC, and composed of
tumor cells showing morphological features intermediate
between HCC and CC [1]. The above definition of CHC by
World Health Organization (WHO) apparently excludes
those tumors in which either forms of growth are
insufficiently differentiated for positive identification [3].
Many liver tumors with intermediate features, anyhow,
comprise significant portion of CHCs, and their diagnosis
remains challenging. Several cases equivalent to the
type III by Taguchi et al. have been reported and described
as a tumor comprised of small cells with a phenotype
intermediate between hepatocytes and cholangiocytes
[4,5]. Robrechts et al. described “primary liver progenitor
cell tumor” as a monomorphic population of small cells
with scant cytoplasm and a trabecular architecture, with an
immunophenotype intermediate between that of hepato-
cytes and that of biliary epithelium [4], while Theise et al.
reported “stem cell tumors” as a mixed population of oval
cells dedifferentiating into both hepatocytic and biliary
type epithelia [5].
The present case seemed to be only composed of HCC at
firstglance.Butthemajorityofthetumorwasthoughttobe
the biphenotypic components with tumor growth pattern
ofHCCandmucin-containingcolumnarcellsformingtrue
glands. Glandular portions were compatible with CC, for
the tumor cells were positive for biliary epithelial makers
and producing mucin. The mucin-producing glands in the
thick trabeculae and irregularly shaped islands had unique
features, which have been hardly reported as a part of
features in HCC. Their morphological phenotype was
different from that of typical CC, in that these glands were
located in the seemingly HCC-like trabeculae and clusters
without desmoplastic changes. And the present case is
definitely different from the pseudoglandular or pseudoa-
cinar variant of HCCs, for the latter shows complete
negative reaction in mucin staining [3]. The present case is
also different from the previously reported ‘primary liver
tumor of intermediated phenotype’, in that this tumor was
notcomposedofthesmalluniformtumorcells.Wesuggest
that the present case is a primary liver carcinoma with dual
phenotypes of HCC and CC, supporting the concepts that
humanhepatocarcinogenesismaybebasedontransforma-
tion of progenitor cells which can imply divergent
differentiation.
Three explanations of the histogenesis of CHC were
suggested parallel to the classification: as a collision or
intermingling of two independent primary tumors; as the
transformation of a primary HCC or CC into the other;
and as differentiation from a bipotential hepatic progeni-
tor cell into morphologically different malignant compo-
nents [5]. Recent studies confirm the existence of a hepatic
progenitor cell population in humans within the liver,
though their role in human hepatocarcinogenesis has not
been confirmed [6].
Wu et al. have reported that approximately 30% of
morphologically pure HCCs showed immunohistochem-
ical evidence of biliary differentiation [7]. In animal
models of hepatocarcinogenesis there are proliferations of
small, undifferentiated, oval shaped cells which are
referred to as ‘oval cells’ [6]. These cells are thought to be
facultative bipotential progenitor cells (or stem cells) and
to be related to the development of hepatocellular
malignancies. Although more elaborate explanation of
the hepatocarcinogenesis is needed, data accumulated so
far support the hypothesis of carcinogenesis from hepatic
progenitor cells with a dual potential. The small tubule-
forming cells around dysplastic nodules in the present case
were pretty similar to the ‘oval-like’ cells, as were the
‘transitional’ cells described by Theise et al [5]. As
described in the cases of Theise et al. [5], the undiffer-
entiated cells merge with hepatocytes in the cirrhotic
nodules, and are contiguous with proliferative biliary
epithelium in the surrounding fibrous connective tissue,
suggesting both the hepatocytic and biliary components
are arising from the undifferentiated population.
There are no markers that are absolutely indicative of stem
cellsintheliver.Whilec-kithasbeenprovedtobesuggestive
in some work, chromogranin-A and CD34 have been
reported to be expressed by human hepatic stem cells [8].
Previous work has demonstrated that hepatoblasts in
human livers co-express CK19 and the antigen recognized
by monoclonal antibody HepPar1 [9]. In the present case,
the small oval-shaped cells were positive for CK19, but
showedonlylimitedimmunoreactivityforHepPar1.Evenif
the oval-shaped cells with monotonous features in this case
were not the exactly same hepatic progenitor cells, they can
be considered to display in-between stages from undiffer-
entiated progenitor cells to differentiated hepatocytes.
Immunohistological stains for CK have been considered to
be useful to distinguish HCC and CC, for CK expression is
believed to be preserved during the neoplastic transforma-
tion. Specifically, HCC was positive for CK8, CK18, and
CC was positive for CK7 and CK19 in addition to the
former CKs [8]. Tickoo et al. suggested that CC-like areas
to be more positive for CK7 with a higher tendency for
immunoreactivity for CK19 than HCC-like areas [2].
Absolute dependence on these markers may at times be
diagnostically misleading.
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Cases Journal 2009, 2:6789 http://casesjournal.com/casesjournal/article/view/6789Using in situ hybridization for albumin messenger
ribonucleic acid (mRNA), a sensitive and specific hepato-
cellular marker, Tickoo et al. confirmed biphenotypic
differentiation of CHCs after demonstrating positivity for
both hepatocellular (albumin mRNA) and biliary CK
markers [2]. D’Errico et al. have reported focal positivity
for albumin mRNA in four of six peripheral CCs, as well as
in biliary cystadenocarcinomas even without the morpho-
logical evidence of hepatocellular carcinoma differentia-
tion in these cases [10]. Even the border between pure
HCCs and pure CCs could be blurred by the immunohis-
tochemical assessment on the phenotype expression. More
supportive studies will be needed in the future. These
results may indicate primary liver tumor with various
phenotypic expressions could originate from hepatocytic
progenitor cells.
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